Brigit Biofarmaka Teknologi Tbk. vs Djasa Ubersakti Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume), while Djasa Ubersakti Tbk. trades at Rp70 (market cap 103.5B, 856.3K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is the larger of the two by market cap, and Djasa Ubersakti Tbk. is more actively traded (856.3K versus 324K). Which is the better fit depends on your goals.
| OBAT | PTDU | |
|---|---|---|
Market Cap | 166.01B | 103.5B |
Volume | 324K | 856.3K |
Lot | 3.24K | 8.56K |
Turnover | 77.68M | — |
Average Price | 239.75 | — |
Value | 77.68M | — |
Indicative Equilibrium Price | 240 | — |
Indicative Equilibrium Volume | 1 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Djasa Ubersakti Tbk (the Company) was established dated February 22, 1971 based on Notarial Deed No. 09 dari Shella Falianti S.H. Notary in Jakarta. The Company started its commercialoperations in 1971.
Read more on PTDU →